Pediatria pre prax 5/2020
Myths and pitfalls in management of patient with infantile hemangioma
Infantile hemangioma (IH) occurs in 5 to 10 % of children under one year of age. This benign vascular tumor is characterized by three phases of growth – proliferation, plateau, involution. Superficial hemangiomas reach their maximum size in 6 to 8 months, in deep ones rarely up to 2 years. Modern non-selective β-blocker therapy – propranolol – offers children an effective, safe and non-invasive solution. Starting the therapy in the proliferative phase is crucial for effectiveness.
Keywords: infantile hemangioma, propranolol
